Table 3 Clinical Trial Evaluation Schedule
From: Phase-I trial of survivin inhibition with EZN-3042 in dogs with spontaneous lymphoma
| Â | Time Point | |||
|---|---|---|---|---|
Procedure | Day 0 | Day 3–4 | Day 7 | Day 8 |
Lymph node biopsy (qRT-PCR, IHC) +/− PBMC collection | X |  |  | X |
History, physical exam, response assessment | X | X | X | X |
CBC, Biochemistry, PT, PTT, Urinalysis | X | X | X | Â |
QOL Questionnaire | X | X | X | X |
Body Weight | X | X | X | X |
EZN-3042 Administration | X | X | X | Â |